Request Free Sample
×
Selective Estrogen Receptor Degraders Therapeutic Market
ID: MRFR/HC/37374-HCR
128 Pages
October 2025
Informe de investigación de mercado terapéutico de degradadores selectivos de receptores de estrógeno (SERD) por aplicación (cáncer de mama, cáncer de ovario, cáncer de endometrio, cáncer de próstata), por tipo de medicamento (oral, intravenoso, subcutáneo), por mecanismo de acción (degradación selectiva del receptor de estrógeno, modulación del receptor de estrógeno, terapias combinadas), por uso final (hospitales, clínicas especializadas, atención domiciliaria) y por región (Norteamérica, Europa, Sudamérica, Asia Pacífico, Medio Oriente y ... leer más
Las empresas clave en el mercado Selective Estrogen Receptor Degraders Therapeutic Market incluyen
Alcance del informe
FAQs
What is the projected market valuation for the Selective Estrogen Receptor Degraders (SERD) Therapeutic Market by 2035?
The projected market valuation for the SERD Therapeutic Market is expected to reach 16.42 USD Billion by 2035.
What was the market valuation of the SERD Therapeutic Market in 2024?
The market valuation of the SERD Therapeutic Market was 4.205 USD Billion in 2024.
What is the expected CAGR for the SERD Therapeutic Market during the forecast period 2025 - 2035?
The expected CAGR for the SERD Therapeutic Market during the forecast period 2025 - 2035 is 13.18%.
Which key players are leading the SERD Therapeutic Market?
Key players in the SERD Therapeutic Market include AstraZeneca, Pfizer, Novartis, Eli Lilly and Company, Gilead Sciences, Bristol-Myers Squibb, Amgen, Merck & Co., and Sanofi.
What are the primary applications of SERDs in cancer treatment?
The primary applications of SERDs in cancer treatment include Breast Cancer, Ovarian Cancer, Endometrial Cancer, and Prostate Cancer.
How does the market for SERDs in Breast Cancer compare to other applications?
The market for SERDs in Breast Cancer is projected to grow from 1.5 USD Billion to 6.0 USD Billion, indicating a strong focus on this application.
What are the different drug types available in the SERD Therapeutic Market?
The SERD Therapeutic Market includes drug types such as Oral, Intravenous, and Subcutaneous, with Oral expected to grow from 1.5 USD Billion to 6.5 USD Billion.
What mechanisms of action are associated with SERDs?
Mechanisms of action for SERDs include Selective Estrogen Receptor Degradation, Estrogen Receptor Modulation, and Combination Therapies, with the former projected to grow significantly.
What is the expected growth in the end-use segment of the SERD Therapeutic Market?
The end-use segment for SERDs, particularly in Hospitals, is expected to grow from 1.6825 USD Billion to 6.728 USD Billion.
How do specialty clinics and homecare compare in the SERD Therapeutic Market?
Specialty Clinics and Homecare are projected to grow from 1.2615 USD Billion to 5.048 USD Billion and from 1.2615 USD Billion to 4.684 USD Billion, respectively.
Descargar muestra gratis
Complete el formulario a continuación para recibir una muestra gratuita de este informe
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Estudio de caso
Aerospace & Defense
Deja un comentario